IS5699A - Ný notkun - Google Patents

Ný notkun

Info

Publication number: IS5699A
Authority: IS; Iceland
Prior art keywords: new use; new
Prior art date: 1998-05-04

Application number

IS5699A

Other languages

English (en)

Inventor

Gurley David

Lanthorn Thomas

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-04

Filing date

2000-11-01

Publication date

2000-11-01

2000-11-01 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2000-11-01 Publication of IS5699A publication Critical patent/IS5699A/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Food Science & Technology (AREA)
General Physics & Mathematics (AREA)
Biotechnology (AREA)
Pathology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Addiction (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

IS5699A 1998-05-04 2000-11-01 Ný notkun IS5699A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/071,826 US6277870B1 (en)	1998-05-04	1998-05-04	Use
PCT/SE1999/000700 WO1999056745A1 (en)	1998-05-04	1999-04-28	New use

Publications (1)

Publication Number	Publication Date
IS5699A true IS5699A (is)	2000-11-01

Family

ID=22103848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5699A IS5699A (is)	1998-05-04	2000-11-01	Ný notkun

Country Status (26)

Country	Link
US (2)	US6277870B1 (is)
EP (1)	EP1079828B1 (is)
JP (1)	JP2002513757A (is)
KR (1)	KR20010043266A (is)
CN (2)	CN1299279A (is)
AR (1)	AR016217A1 (is)
AT (1)	ATE249827T1 (is)
AU (1)	AU770849B2 (is)
BR (1)	BR9910180A (is)
CA (1)	CA2331070A1 (is)
DE (1)	DE69911400T2 (is)
EE (1)	EE200000640A (is)
HU (1)	HUP0102504A3 (is)
ID (1)	ID27289A (is)
IL (1)	IL139145A0 (is)
IS (1)	IS5699A (is)
MY (1)	MY116027A (is)
NO (1)	NO20005503L (is)
PL (1)	PL343923A1 (is)
RU (1)	RU2225203C2 (is)
SK (1)	SK284608B6 (is)
TR (1)	TR200003244T2 (is)
TW (1)	TW542718B (is)
UA (1)	UA65617C2 (is)
WO (1)	WO1999056745A1 (is)
ZA (1)	ZA200006133B (is)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6277870B1 (en)	1998-05-04	2001-08-21	Astra Ab	Use
EP1453828A2 (en) *	2001-10-16	2004-09-08	AstraZeneca AB	Azabicyclic compounds for the treatment of fibromyalgia syndrome
BR0214929A (pt) *	2001-12-14	2006-05-30	Targacept Inc	métodos e composições para o tratamento de distúrbios do sistema nervoso central
US7091357B2 (en) *	2001-12-26	2006-08-15	University Of Kentucky Research Foundation	Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
US7781396B2 (en) *	2002-01-31	2010-08-24	Tel Aviv University Future Technology Development L.P.	Peptides directed for diagnosis and treatment of amyloid-associated disease
US20040052928A1 (en) *	2002-09-06	2004-03-18	Ehud Gazit	Peptides and methods using same for diagnosing and treating amyloid-associated diseases
US20030162770A1 (en)	2002-02-22	2003-08-28	Davis Bonnie M.	Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
US20030236287A1 (en) *	2002-05-03	2003-12-25	Piotrowski David W.	Positive allosteric modulators of the nicotinic acetylcholine receptor
CA2487236A1 (en)	2002-05-09	2003-11-20	Memory Pharmaceuticals Corporation	Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
EP2298759A1 (en)	2002-08-30	2011-03-23	Memory Pharmaceuticals Corporation	Anabaseine derivatives useful in the treatment of neurodegenerative diseases
CZ2005252A3 (cs)	2002-09-25	2005-11-16	Memory Pharmaceuticals Corporation	Indazoly, benzothiazoly a benzoisothiazoly jejich příprava a použití
US7491699B2 (en)	2002-12-09	2009-02-17	Ramot At Tel Aviv University Ltd.	Peptide nanostructures and methods of generating and using the same
DE602004020179D1 (de)	2003-01-07	2009-05-07	Univ Ramot	Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
EP1663199B1 (en)	2003-09-25	2013-04-03	Tel Aviv University Future Technology Development L.P.	Compositions and methods using same for treating amyloid-associated diseases
WO2005031362A2 (en) *	2003-10-02	2005-04-07	Ramot At Tel Aviv University Ltd.	Novel antibacterial agents and methods of identifying and utilizing same
ES2295973T3 (es)	2003-12-22	2008-04-16	Memory Pharmaceuticals Corporation	Indoles, 1h-indazoles, 1,2-bencisoxazoles, y 1,2-bencisotiazoles, y preparacion y usos de los mismos.
WO2005092890A2 (en)	2004-03-25	2005-10-06	Memory Pharmaceuticals Corporation	Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
WO2006001894A1 (en)	2004-04-22	2006-01-05	Memory Pharmaceutical Corporation	Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
JP2007538011A (ja)	2004-05-07	2007-12-27	メモリー・ファーマシューティカルズ・コーポレイション	１ｈ−インダゾール、ベンゾチアゾール、１，２−ベンゾイソキサゾール、１，２−ベンゾイソチアゾール、およびクロモン、ならびにそれらの調製および使用
WO2006006172A2 (en) *	2004-07-15	2006-01-19	Ramot At Tel Aviv University Ltd.	Use of anti-amyloid agents for treating and typing pathogen infections
US8568637B2 (en)	2004-08-02	2013-10-29	Ramot At Tel-Aviv University Ltd.	Method of forming a fiber made of peptide nanostructures
WO2006018850A2 (en)	2004-08-19	2006-02-23	Tel Aviv University Future Technology Development L.P.	Compositions for treating amyloid associated diseases
US7786086B2 (en)	2004-09-08	2010-08-31	Ramot At Tel-Aviv University Ltd.	Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
AU2005319248A1 (en)	2004-12-22	2006-06-29	Memory Pharmaceuticals Corporation	Nicotinic alpha-7 receptor ligands and preparation and uses thereof
SI1883451T1 (sl) *	2005-04-13	2011-04-29	Neuraxon Inc	Substituirane indolne spojine z NOS inhibitorno aktivnostjo
US8106066B2 (en)	2005-09-23	2012-01-31	Memory Pharmaceuticals Corporation	Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
EP1973928A2 (en) *	2005-10-11	2008-10-01	Ramot at Tel-Aviv University Ltd.	Self-assembled fmoc-ff hydrogels
US7879212B2 (en) *	2005-11-03	2011-02-01	Ramot At Tel-Aviv University Ltd.	Peptide nanostructure-coated electrodes
US20070134169A1 (en) *	2005-12-11	2007-06-14	Rabinoff Michael D	Methods for smoking cessation or alcohol cessation or other addiction cessation
TW200808780A (en) *	2006-04-13	2008-02-16	Neuraxon Inc	1,5 and 3,6- substituted indole compounds having NOS inhibitory activity
US8314119B2 (en)	2006-11-06	2012-11-20	Abbvie Inc.	Azaadamantane derivatives and methods of use
AU2008321353A1 (en) *	2007-11-16	2009-05-22	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Methods for treating visceral pain
EA201000808A1 (ru) *	2007-11-16	2011-04-29	Ньюраксон, Инк.	Индольные соединения и способы лечения висцеральной боли
LT2889033T (lt)	2008-11-19	2018-07-10	Forum Pharmaceuticals Inc.	Šizofrenijos negatyvių simptomų gydymas (r)-7-chlor-n-(chinuklidin-3-il)benzo[b]tiofen-2-karboksamidu ir jo farmaciniu požiūriu priimtinomis druskomis
WO2010132423A1 (en) *	2009-05-11	2010-11-18	Envivo Pharmaceuticals, Inc.	Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
MY165234A (en)	2010-05-17	2018-03-14	Forum Pharmaceuticals Inc	A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
PE20131394A1 (es)	2010-09-23	2014-01-11	Abbvie Inc	Monohidrato de derivados de aza-adamantano
HK1208356A1 (en)	2012-05-08	2016-03-04	Forum Pharmaceuticals Inc.	Methods of maintaining, treating or improving cognitive function

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2649009B1 (fr) *	1989-07-03	1991-10-11	Oreal	Procede de teinture des fibres keratiniques a base de monohydroxyindole et de 5,6-dihydroxyindole et composition mise en oeuvre
US5272155A (en) *	1991-12-05	1993-12-21	Abbott Laboratories	(+)-2-methylpiperidine as modulator of cholinergic systems
SK281423B6 (sk) *	1992-03-12	2001-03-12	Smithkline Beecham Plc	Kondenzované indolové deriváty, spôsob ich výroby, farmaceutické prostriedky s ich obsahom a ich použitie
CN1137753A (zh) *	1993-09-10	1996-12-11	赛托医学有限公司	作为胆碱能受体激动剂和拮抗剂的阿吡巴替丁及其衍生物
CN1056846C (zh) *	1994-08-24	2000-09-27	阿斯特拉公司	治疗学上有效的螺－氮杂二环化合物
SE9600683D0 (sv) *	1996-02-23	1996-02-23	Astra Ab	Azabicyclic esters of carbamic acids useful in therapy
AR013184A1 (es) *	1997-07-18	2000-12-13	Astrazeneca Ab	Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
US6277870B1 (en)	1998-05-04	2001-08-21	Astra Ab	Use

1998
- 1998-05-04 US US09/071,826 patent/US6277870B1/en not_active Expired - Fee Related
1999
- 1999-04-21 TW TW088106373A patent/TW542718B/zh not_active IP Right Cessation
- 1999-04-22 AR ARP990101861A patent/AR016217A1/es unknown
- 1999-04-28 UA UA2000126907A patent/UA65617C2/uk unknown
- 1999-04-28 JP JP2000546771A patent/JP2002513757A/ja active Pending
- 1999-04-28 AT AT99948542T patent/ATE249827T1/de not_active IP Right Cessation
- 1999-04-28 HU HU0102504A patent/HUP0102504A3/hu unknown
- 1999-04-28 TR TR2000/03244T patent/TR200003244T2/xx unknown
- 1999-04-28 RU RU2000130209/15A patent/RU2225203C2/ru not_active IP Right Cessation
- 1999-04-28 IL IL13914599A patent/IL139145A0/xx unknown
- 1999-04-28 CN CN99805760A patent/CN1299279A/zh active Pending
- 1999-04-28 DE DE69911400T patent/DE69911400T2/de not_active Expired - Fee Related
- 1999-04-28 BR BR9910180-7A patent/BR9910180A/pt not_active IP Right Cessation
- 1999-04-28 WO PCT/SE1999/000700 patent/WO1999056745A1/en not_active Application Discontinuation
- 1999-04-28 EE EEP200000640A patent/EE200000640A/xx unknown
- 1999-04-28 EP EP99948542A patent/EP1079828B1/en not_active Expired - Lifetime
- 1999-04-28 CN CNA2004100880671A patent/CN1637149A/zh active Pending
- 1999-04-28 AU AU43023/99A patent/AU770849B2/en not_active Ceased
- 1999-04-28 SK SK1570-2000A patent/SK284608B6/sk unknown
- 1999-04-28 CA CA002331070A patent/CA2331070A1/en not_active Abandoned
- 1999-04-28 PL PL99343923A patent/PL343923A1/xx not_active Application Discontinuation
- 1999-04-28 KR KR1020007012221A patent/KR20010043266A/ko not_active Ceased
- 1999-05-04 MY MYPI99001750A patent/MY116027A/en unknown
- 1999-05-28 ID IDW20002260A patent/ID27289A/id unknown
2000
- 2000-10-30 ZA ZA200006133A patent/ZA200006133B/en unknown
- 2000-11-01 NO NO20005503A patent/NO20005503L/no not_active Application Discontinuation
- 2000-11-01 IS IS5699A patent/IS5699A/is unknown
2001
- 2001-03-20 US US09/812,269 patent/US6861443B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AR016217A1 (es)	2001-06-20
PL343923A1 (en)	2001-09-10
AU770849B2 (en)	2004-03-04
WO1999056745A1 (en)	1999-11-11
UA65617C2 (uk)	2004-04-15
DE69911400T2 (de)	2004-07-08
IL139145A0 (en)	2001-11-25
BR9910180A (pt)	2001-01-09
US6861443B2 (en)	2005-03-01
RU2225203C2 (ru)	2004-03-10
EE200000640A (et)	2002-04-15
US6277870B1 (en)	2001-08-21
EP1079828A1 (en)	2001-03-07
HUP0102504A3 (en)	2002-12-28
ZA200006133B (en)	2002-01-30
CN1637149A (zh)	2005-07-13
KR20010043266A (ko)	2001-05-25
HK1034205A1 (en)	2001-10-19
NO20005503D0 (no)	2000-11-01
HUP0102504A2 (hu)	2001-11-28
DE69911400D1 (de)	2003-10-23
SK284608B6 (sk)	2005-07-01
AU4302399A (en)	1999-11-23
ID27289A (id)	2001-03-22
US20010041732A1 (en)	2001-11-15
CN1299279A (zh)	2001-06-13
ATE249827T1 (de)	2003-10-15
EP1079828B1 (en)	2003-09-17
CA2331070A1 (en)	1999-11-11
JP2002513757A (ja)	2002-05-14
NO20005503L (no)	2001-01-04
TR200003244T2 (tr)	2001-03-21
MY116027A (en)	2003-10-31
SK15702000A3 (sk)	2001-08-06
TW542718B (en)	2003-07-21

Publication	Publication Date	Title
IS5699A (is)	2000-11-01	Ný notkun
ID25977A (id)	2000-11-16	Popok sekali pakai
ID24555A (id)	2000-07-27	Popok sekali pakai
ID23076A (id)	2000-02-03	Popok sekali pakai
DE69911008D1 (de)	2003-10-09	Gasturbinenkraftstoffeinspritzdüse
DE69936443D1 (de)	2007-08-16	Bedienungspersoneingagabevorrichtung
DE69933567D1 (de)	2006-11-23	Sigmidoskop
DE69904595D1 (de)	2003-01-30	Betacarbolinverbindungen
DE59902874D1 (de)	2002-10-31	Buchsenkontakt
EP1124578A4 (en)	2005-01-19	NEW IMMUNOADJUVANTS
DE69922063D1 (de)	2004-12-30	Fesselballon
ID23083A (id)	2000-02-03	Popok sekali pakai
DE69910986D1 (de)	2003-10-09	Atmosphärenteilchenanalysator
DE69937642D1 (de)	2008-01-10	Trimaranstruktur
DE69927399D1 (de)	2005-10-27	Zahnätzmittel
DE69907576D1 (de)	2003-06-12	Solenoidantriebsvorrichtung
DE69902880D1 (de)	2002-10-17	Resonanzumwandlerschaltung
DE69936434D1 (de)	2007-08-16	Bildverabeitungsvorrichtung
DE69933674D1 (de)	2006-11-30	Nagigationsvorrichtung
DE59908057D1 (de)	2004-01-29	Underdruckhandhabungseinrichung
FI980187A0 (fi)	1998-01-28	Vattenturbinsystem
DE69918165D1 (de)	2004-07-22	Doramectinformulierungen
DE69808524D1 (de)	2002-11-07	Refinerplattensegment
DE69907543D1 (de)	2003-06-12	Röhrchenindexiervorrichtung
DE69907833D1 (de)	2003-06-18	Elektrolumineszenselement